Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas.
Tseng KY, Chung MH, Sytwu HK, Lee HM, Chen KY, Chang C, Lin CK, Yen CH, Chen JH, Lin GJ, Ma HI, Yeh YS, Ju DT, Liu MY, Hueng DY.
Tseng KY, et al. Among authors: lin ck, lin gj.
J Neurooncol. 2010 Nov;100(2):217-23. doi: 10.1007/s11060-010-0164-2. Epub 2010 Apr 29.
J Neurooncol. 2010.
PMID: 20428925